149 related articles for article (PubMed ID: 7970204)
1. Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus.
Rammes G; Parsons C; Müller W; Swandulla D
Neurosci Lett; 1994 Jul; 175(1-2):21-4. PubMed ID: 7970204
[TBL] [Abstract][Full Text] [Related]
2. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones.
Rammes G; Swandulla D; Spielmanns P; Parsons CG
Neuropharmacology; 1998; 37(10-11):1299-320. PubMed ID: 9849667
[TBL] [Abstract][Full Text] [Related]
3. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
Yamada KA; Turetsky DM
Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
[TBL] [Abstract][Full Text] [Related]
4. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices.
Rammes G; Swandulla D; Collingridge GL; Hartmann S; Parsons CG
Br J Pharmacol; 1996 Mar; 117(6):1209-21. PubMed ID: 8882618
[TBL] [Abstract][Full Text] [Related]
5. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
Donevan SD; Rogawski MA
Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
[TBL] [Abstract][Full Text] [Related]
6. Long-term potentiation alters the modulator pharmacology of AMPA-type glutamate receptors.
Lin B; Brücher FA; Colgin LL; Lynch G
J Neurophysiol; 2002 Jun; 87(6):2790-800. PubMed ID: 12037181
[TBL] [Abstract][Full Text] [Related]
7. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
Johansen TH; Chaudhary A; Verdoorn TA
Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
[TBL] [Abstract][Full Text] [Related]
8. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
[TBL] [Abstract][Full Text] [Related]
9. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.
Arai AC; Kessler M; Rogers G; Lynch G
Mol Pharmacol; 2000 Oct; 58(4):802-13. PubMed ID: 10999951
[TBL] [Abstract][Full Text] [Related]
10. Synaptic potentiation of dual-component excitatory postsynaptic currents in the rat hippocampus.
Clark KA; Collingridge GL
J Physiol; 1995 Jan; 482 ( Pt 1)(Pt 1):39-52. PubMed ID: 7730988
[TBL] [Abstract][Full Text] [Related]
11. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
Desai MA; Burnett JP; Ornstein PL; Schoepp DD
J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
Kessler M; Arai A; Quan A; Lynch G
Mol Pharmacol; 1996 Jan; 49(1):123-31. PubMed ID: 8569697
[TBL] [Abstract][Full Text] [Related]
13. Expression of early hippocampal CA1 LTP does not lead to changes in AMPA-EPSC kinetics or sensitivity to cyclothiazide.
Rammes G; Zeilhofer HU; Collingridge GL; Parsons CG; Swandulla D
Pflugers Arch; 1999 Jan; 437(2):191-6. PubMed ID: 9929558
[TBL] [Abstract][Full Text] [Related]
14. Involvement of post-synaptic kainate receptors during synaptic transmission between unitary connections in rat neocortex.
Ali AB
Eur J Neurosci; 2003 Jun; 17(11):2344-50. PubMed ID: 12814386
[TBL] [Abstract][Full Text] [Related]
15. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
Partin KM; Mayer ML
Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699
[TBL] [Abstract][Full Text] [Related]
16. AMPA-preferring receptors mediate excitatory synaptic inputs to retinal ganglion cells.
Lukasiewicz PD; Wilson JA; Lawrence JE
J Neurophysiol; 1997 Jan; 77(1):57-64. PubMed ID: 9120596
[TBL] [Abstract][Full Text] [Related]
17. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
Kapus G; Székely JI; Durand J; Ruiz A; Tarnawa I
Brain Res Bull; 2000 Aug; 52(6):511-7. PubMed ID: 10974490
[TBL] [Abstract][Full Text] [Related]
18. Negative allosteric modulators of AMPA-preferring receptors inhibit [(3)H]GABA release in rat striatum.
Harsing LG; Csillik-Perczel V; Ling I; Sólyom S
Neurochem Int; 2000 Jul; 37(1):33-45. PubMed ID: 10781843
[TBL] [Abstract][Full Text] [Related]
19. Regulation of EPSPs by the synaptic activation of GABAB autoreceptors in rat hippocampus.
Davies CH; Collingridge GL
J Physiol; 1996 Oct; 496 ( Pt 2)(Pt 2):451-70. PubMed ID: 8910229
[TBL] [Abstract][Full Text] [Related]
20. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655.
Palmer AJ; Lodge D
Eur J Pharmacol; 1993 Jan; 244(2):193-4. PubMed ID: 7679352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
